Glucose-Responsive Self-Healing Bilayer Drug Microneedles Promote Diabetic Wound Healing Via a Trojan-Horse Strategy
Source abstract
Abstract
Chronic nonhealing wounds are serious complications of diabetes with a high morbidity, and they can lead to disability or death. Conventional drug therapy is ineffective for diabetic wound healing because of the complex environment of diabetic wounds and the depth of drug penetration. Here, we developed a self-healing, dual-layer, drug-carrying microneedle (SDDMN) for diabetic wound healing. This SDDMN can realize transdermal drug delivery and broad-spectrum sterilization without drug resistance and meets the multiple needs of the diabetic wound healing process. Quaternary ammonium chitosan cografted with dihydrocaffeic acid (Da) and l-arginine and oxidized hyaluronic acid-dopamine are the main parts of the self-healing hydrogel patch. Methacrylated poly(vinyl alcohol) (methacrylated PVA) and phenylboronic acid (PBA) were used as the main part of the MN, and gallium porphyrin modified with 3-amino-1,2 propanediol (POGa) and insulin were encapsulated at its tip. Under hyperglycaemic conditions, the PBA moiety in the MN reversibly formed a glucose-boronic acid complex that promoted the rapid release of POGa and insulin. POGa is disguised as hemoglobin through a Trojan-horse strategy, which is then taken up by bacteria, allowing it to target bacteria and infected lesions. Based on the synergistic properties of these components, SDDMN-POGa patches exhibited an excellent biocompatibility, slow drug release, and antimicrobial properties. Thus, these patches provide a potential therapeutic approach for the treatment of diabetic wounds.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Advancements in Transdermal Drug Delivery · Diabetic Foot Ulcer Assessment and Management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, Hospital of Stomatology, Jilin University, 763 Heguang Road, Changchun 130021, P. R. China
Funding
National Natural Science Foundation of China
References (57)
Show source-provided references
1. 10.2337/dci18-000710.2337/dci18-0007 ↗
2. 10.1016/j.carbpol.2022.12019810.1016/j.carbpol.2022.120198 ↗
3. 10.1016/j.ijbiomac.2019.08.00710.1016/j.ijbiomac.2019.08.007 ↗
4. 10.2147/IJN.S21812010.2147/IJN.S218120 ↗
5. 10.1016/j.addr.2018.07.01910.1016/j.addr.2018.07.019 ↗
6. 10.1016/j.trsl.2018.10.00110.1016/j.trsl.2018.10.001 ↗
7. 10.1021/acs.accounts.0c0086410.1021/acs.accounts.0c00864 ↗
8. 10.1001/jama.2018.1242610.1001/jama.2018.12426 ↗
9. 10.1016/S0140-6736(01)05321-110.1016/S0140-6736(01)05321-1 ↗
10. 10.1039/D0TB02177F10.1039/D0TB02177F ↗
11. 10.1007/s00125-010-1893-710.1007/s00125-010-1893-7 ↗
12. 10.1126/scitranslmed.aat752010.1126/scitranslmed.aat7520 ↗
13. 10.1016/j.bioactmat.2021.12.03410.1016/j.bioactmat.2021.12.034 ↗
14. 10.1126/scitranslmed.aat752010.1126/scitranslmed.aat7520 ↗
15. 10.3390/ijms2206287610.3390/ijms22062876 ↗
16. 10.3389/fbioe.2022.82796010.3389/fbioe.2022.827960 ↗
17. 10.1016/j.jinorgbio.2017.02.00110.1016/j.jinorgbio.2017.02.001 ↗
18. 10.1126/sciimmunol.aan569210.1126/sciimmunol.aan5692 ↗
19. 10.1002/adma.20150602510.1002/adma.201506025 ↗
20. 10.1016/j.cej.2022.13547510.1016/j.cej.2022.135475 ↗
21. 10.1002/adhm.20210013510.1002/adhm.202100135 ↗
22. 10.1016/j.biomaterials.2012.04.02210.1016/j.biomaterials.2012.04.022 ↗
23. 10.1088/1758-5090/aac00c10.1088/1758-5090/aac00c ↗
24. 10.3389/fbioe.2023.107572010.3389/fbioe.2023.1075720 ↗
25. 10.1039/C7PY00519A10.1039/C7PY00519A ↗
26. 10.1016/j.carbpol.2019.11580310.1016/j.carbpol.2019.115803 ↗
27. 10.1016/j.biomaterials.2017.01.01110.1016/j.biomaterials.2017.01.011 ↗
28. 10.1002/adma.20150076210.1002/adma.201500762 ↗
29. 10.1002/adhm.20160072010.1002/adhm.201600720 ↗
30. 10.1016/j.ijbiomac.2019.10.11310.1016/j.ijbiomac.2019.10.113 ↗
31. 10.1016/j.ijbiomac.2020.03.18210.1016/j.ijbiomac.2020.03.182 ↗
32. 10.1016/j.carbpol.2020.11636410.1016/j.carbpol.2020.116364 ↗
33. 10.1021/acsnano.2c0506910.1021/acsnano.2c05069 ↗
34. 10.1088/1748-605X/ab950f10.1088/1748-605X/ab950f ↗
35. 10.1016/j.carbpol.2022.11964810.1016/j.carbpol.2022.119648 ↗
36. 10.1016/j.ijpharm.2024.12393110.1016/j.ijpharm.2024.123931 ↗
37. 10.1016/j.carbpol.2019.03.03010.1016/j.carbpol.2019.03.030 ↗
38. 10.1016/j.jcis.2018.10.05610.1016/j.jcis.2018.10.056 ↗
39. 10.1002/adfm.20200237010.1002/adfm.202002370 ↗
40. 10.1016/j.cej.2019.05.04310.1016/j.cej.2019.05.043 ↗
41. 10.1021/acsnano.1c1104010.1021/acsnano.1c11040 ↗
42. 10.1002/adma.20200776110.1002/adma.202007761 ↗
43. 10.1016/j.actbio.2022.04.04110.1016/j.actbio.2022.04.041 ↗
44. 10.1002/smll.20210135610.1002/smll.202101356 ↗
45. 10.1046/j.1365-2958.1999.01175.x10.1046/j.1365-2958.1999.01175.x ↗
46. 10.1016/j.carbpol.2022.11963110.1016/j.carbpol.2022.119631 ↗
47. 10.1186/s12951-023-02025-810.1186/s12951-023-02025-8 ↗
48. 10.1021/acsinfecdis.1c0028010.1021/acsinfecdis.1c00280 ↗
49. 10.1021/acs.molpharmaceut.3c0022310.1021/acs.molpharmaceut.3c00223 ↗
50. 10.1074/jbc.M70837220010.1074/jbc.M708372200 ↗
51. 10.1146/annurev-micro-090110-10285110.1146/annurev-micro-090110-102851 ↗
52. 10.1007/s10534-005-4863-710.1007/s10534-005-4863-7 ↗
53. 10.1016/j.jinorgbio.2009.09.01210.1016/j.jinorgbio.2009.09.012 ↗
54. 10.1021/acsami.8b0318510.1021/acsami.8b03185 ↗
55. 10.2147/IJN.S41099610.2147/IJN.S410996 ↗
56. 10.1016/j.bioactmat.2023.03.00510.1016/j.bioactmat.2023.03.005 ↗
57. 10.1016/j.bioactmat.2021.01.03510.1016/j.bioactmat.2021.01.035 ↗